IPRIPR2024-00201Terminated-Adverse Judgment
Biocon Biologics Inc. et al.v.Regeneron Pharmaceuticals, Inc.
IPR challenge of US 10888601.
Type
IPR
Filed
Nov 20, 2023
Instituted
Jan 16, 2024
Decided
Jul 30, 2024
Patent
Application
16397267
Inventor
George D. YANCOPOULOS
Granted
Jan 12, 2021
01
Timeline
3 milestones
2023-11-20Petition filed
2024-01-16Institution
2024-07-30Terminated
02
Parties & counsel
Petitioner
Biocon Biologics Inc. et al.
Counsel
Molino, Paulet al
Patent Owner
Regeneron Pharmaceuticals, Inc.
Counsel
Brausa, Adamet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →